Public Sector Pension Investment Board Invests $5.11 Million in Astrana Health, Inc. (NASDAQ:ASTH)

Public Sector Pension Investment Board purchased a new stake in Astrana Health, Inc. (NASDAQ:ASTH) in the third quarter, Holdings Channel.com reports. The firm purchased 88,124 shares of the company’s stock, valued at approximately $5,106,000.

A number of other hedge funds have also recently bought and sold shares of the business. GAMMA Investing LLC acquired a new stake in shares of Astrana Health during the third quarter worth approximately $34,000. Nisa Investment Advisors LLC acquired a new position in Astrana Health during the 3rd quarter worth $35,000. KBC Group NV bought a new stake in shares of Astrana Health in the 3rd quarter worth about $70,000. Quest Partners LLC acquired a new stake in shares of Astrana Health in the 3rd quarter valued at about $133,000. Finally, Central Pacific Bank Trust Division bought a new position in shares of Astrana Health during the third quarter worth about $160,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Price Performance

Shares of NASDAQ ASTH opened at $43.25 on Monday. Astrana Health, Inc. has a 1-year low of $32.32 and a 1-year high of $63.20. The firm has a market capitalization of $2.43 billion, a PE ratio of 33.27, a P/E/G ratio of 2.00 and a beta of 1.24. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. The business’s fifty day moving average price is $52.79 and its two-hundred day moving average price is $48.04.

Astrana Health (NASDAQ:ASTH) last posted its earnings results on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $478.71 million during the quarter, compared to analyst estimates of $462.01 million. During the same period in the previous year, the business posted $0.47 EPS. On average, research analysts expect that Astrana Health, Inc. will post 1.16 EPS for the current year.

Analysts Set New Price Targets

Several analysts recently weighed in on ASTH shares. TD Cowen began coverage on Astrana Health in a report on Monday, October 14th. They issued a “buy” rating and a $66.00 price objective for the company. KeyCorp assumed coverage on Astrana Health in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Robert W. Baird lifted their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. Truist Financial boosted their target price on shares of Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Finally, BTIG Research raised their price target on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $65.17.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.